ArticlePolymers2025
Use of Natamycin for the Development of Polymer Systems with Antifungal Activity for Packaging Applications.
Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recently, there has been a rapid growth in the use of biodegradable polymers as alternatives to petroleum-based polymers, particularly in the packaging sector, to reduce environmental pollution. In this scenario, the aim of this work was to study the use of different amounts of Natamycin on two polymer systems: one that is non-biodegradable but widely known in the field of packaging and one that is biodegradable and is emerging as a possible replacement, in order to accelerate progress toward the achievement of the sustainable development goals. Both systems were produced through melt mixing followed by compression moulding. Subsequently, they were fully characterized by rheological, morphological, mechanical, thermal, and wettability analyses. Natamycin release was evaluated in water at 4 °C by UV-Vis measurements. The antifungal activity of both polymeric systems containing Natamycin was assessed in vitro against three strains of undesirable filamentous fungi of food interest. The results show that PCL with 5% Natamycin represents an effective biodegradable alternative to EVA for inhibiting undesirable filamentous fungi. More specifically, both systems at 5% showed comparable inhibition zones of about 30 mm.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.